Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls Meeting Abstract

  

Authors:	Shaw, A. T.; Yeap, B. Y.; Solomon, B. J.; Riely, G. J.; Iafrate, A. J.; Shapiro, G.; Costa, D. B.; Butaney, M.; Ou, S. I.; Maki, R. G.; Bang, Y.; Varella-Garcia, M.; Salgia, R.; Wilner, K. D.; Kulig, K.; Selaru, P.; Tang, Y.; Kwak, E. L.; Clark, J. W.; Camidge, D. R.
Abstract Title:	Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls
Meeting Title:	47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	15 Suppl.
Meeting Dates:	2011 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-05-20
Language:	English
ACCESSION:	WOS:000208880302237
PROVIDER:	wos
DOI:	10.1200/jco.2011.29.15_suppl.7507
Notes:	Meeting Abstract: 7507 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141533